Similar articles

• Common heat stable protective antigen in gonococci.

  Ito JI Jr, Corbeil LB, Wunderlich AC, McCutchan JA, Braude AI. Ito JI Jr, et al. Trans Assoc Am Physicians. 1979;92:160-8. Trans Assoc Am Physicians. 1979. PMID: 95067
• [Ways and prospects of producing gonococcal vaccine].

  Bednova VN, Dmitriev GA, Pasternak NI. Bednova VN, et al. Vestn Dermatol Venerol. 1987;(11):41-7. Vestn Dermatol Venerol. 1987. PMID: 3125694 Review. Russian. No abstract available.
• Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies.

  Wetzler LM, Blake MS, Gotschlich EC. Wetzler LM, et al. Trans Assoc Am Physicians. 1989;102:78-90. Trans Assoc Am Physicians. 1989. PMID: 2561644 No abstract available.
• Preliminary studies on the development of a gonococcal vaccine.

  Greenberg I, Diena BB, Kenny CP, Znamirowski R. Greenberg I, et al. Bull World Health Organ. 1971;45(4):531-5. Bull World Health Organ. 1971. PMID: 5004708 Free PMC article. No abstract available.
• Vaccine research for gonococcal infections: where are we?

  Jerse AE, Deal CD. Jerse AE, et al. Sex Transm Infect. 2013 Dec;89 Suppl 4:iv63-8. doi: 10.1136/sextrans-2013-051225. Sex Transm Infect. 2013. PMID: 24243883 Review.